Guangzhou Zhiyi Biotech
Guangzhou Zhiyi Biotech, a leader in the development of Live Biotherapeutic Products (LBPs) and Next Generation Probiotics (NGPs), focuses on the research and development of microbiome-based innovative drugs and new functional food ingredients for the digestive field. By deeply exploring key strains such as Bacteroides fragilis, the company has established global leadership in the development of LBP products from strain selection to product development.
Guangzhou Proforcare
Guangzhou Proforcare Pharmaceuticals Inc., a subsidiary of Zhiyi Biotech, leverages Southern China's largest probiotic library to deliver high-quality microbial solutions. With 8,000m² of labs and GMP-like facilities for commercial-scale production, Proforcare provides comprehensive services including development, manufacturing, supply chain management, and technical support to meet diverse client needs.
